Health Data Management | Partnership Aims to Get Genomic Info to Docs for Prescribing
A new initiative seeks to give clinicians access to a database that can inform them on which drugs might be the most effective in treating patient conditions, based on their genetic composition.
The Innovation Institute and 2bPrecise, a wholly owned subsidiary of Allscripts Healthcare Solutions, have announced an agreement that will enable 2bPrecise to deliver a pharmacogenomics knowledge base to the point of care for providers that are members of The Innovation Institute, as well as other providers that aren’t in the networks of those members.
One of the six member owners of the Innovation Institute is Avera Health, which has developed GeneFolio, which describes how drugs and gene tests are related. Insights from the database are intended to be delivered within providers’ workflows, when they are making treatment decisions. More…